Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients?

This publication has 15 references indexed in Scilit:

• Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia–Reperfusion Injury in the Rat
  Cardiovascular Drugs and Therapy, 2008
• Caffeine Prevents Protection in Two Human Models of Ischemic Preconditioning
  JACC, 2006
• Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction
  JAMA, 2006
• Optimal Windows of Statin Use for Immediate Infarct Limitation
  Circulation, 2004
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention
  Circulation, 2004
• Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
  Physiological Reviews, 2003
• Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway
  JACC, 2003
• Coffee consumption and risk of type 2 diabetes mellitus
  The Lancet, 2002
• The cardiovascular effects of regular and decaffeinated coffee.
  British Journal of Clinical Pharmacology, 1985
• Tolerance to the humoral and hemodynamic effects of caffeine in man.
  Journal of Clinical Investigation, 1981